ExxonMobil, Meta Platforms, UnitedHealth Group, Biogen and NVIDIA are part of the Zacks Market Edge article.
Tracey and Kevin discuss the rocky 2022 stock market and the future of growth stocks.
In many ways, 2022 has been a year like no other, as investors and consumers alike have been looking for signs that the macroeconomic headwinds might eventually ease. October started off in rally mode, but a couple of new economic reports suggest relief is still a way off, sparking a wide-ranging sell-off on Wall Street. To be clear, there was nothing in the way of company-specific news driving these technology stocks lower today.